AnPac Bio-Medical Science Co. Ltd.
(NASDAQ : ANPC)

( )
ANPC After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen, Inc. -0.94%240.321.3%$790.96m
IMMUImmunomedics, Inc. 0.15%85.3011.0%$689.14m
MRNAModerna, Inc. -2.96%65.170.0%$688.38m
GILDGilead Sciences, Inc. -1.33%62.251.0%$574.97m
NVAXNovavax, Inc. 0.86%102.4496.5%$560.41m
ILMNIllumina, Inc. 4.88%286.313.5%$502.92m
REGNRegeneron Pharmaceuticals, Inc. -1.37%557.462.7%$425.08m
BIIBBiogen, Inc. -0.79%270.041.6%$333.15m
VRTXVertex Pharmaceuticals, Inc. -0.26%263.131.9%$328.25m
ALXNAlexion Pharmaceuticals, Inc. -0.37%112.022.0%$278.23m
SRNESorrento Therapeutics, Inc. -4.27%9.191.5%$246.35m
EXASEXACT Sciences Corp. 26.85%94.3120.7%$232.04m
SGENSeattle Genetics, Inc. 0.09%179.436.0%$203.87m
VXRTVaxart, Inc. -4.17%6.890.0%$198.58m
MNTAMomenta Pharmaceuticals, Inc. 0.19%52.393.0%$197.85m

Company Profile

Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China.